Beijing Chunlizhengda Medical Instruments Co., Ltd. (688236.SS)
CNY 13.3
(0.38%)
CNY 13.3
(0.38%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.64 Billion CNY | 7.03% |
| 2022 | 3.4 Billion CNY | 13.67% |
| 2021 | 2.99 Billion CNY | 94.78% |
| 2020 | 1.53 Billion CNY | 27.34% |
| 2019 | 1.2 Billion CNY | 48.43% |
| 2018 | 814.74 Million CNY | 28.58% |
| 2017 | 633.66 Million CNY | 17.32% |
| 2016 | 540.12 Million CNY | 12.99% |
| 2015 | 478.04 Million CNY | 99.3% |
| 2014 | 239.85 Million CNY | 19.55% |
| 2013 | 200.63 Million CNY | 7.0% |
| 2012 | 187.5 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.54 Billion CNY | -2.93% |
| 2024 Q2 | 3.63 Billion CNY | 2.55% |
| 2024 Q3 | 3.49 Billion CNY | -3.8% |
| 2023 Q3 | 3.35 Billion CNY | -3.24% |
| 2023 Q1 | 3.39 Billion CNY | -0.54% |
| 2023 Q2 | 3.47 Billion CNY | 2.39% |
| 2023 FY | 3.64 Billion CNY | 7.03% |
| 2023 Q4 | 3.64 Billion CNY | 8.62% |
| 2022 Q4 | 3.4 Billion CNY | 9.65% |
| 2022 Q2 | 3.1 Billion CNY | 2.2% |
| 2022 FY | 3.4 Billion CNY | 13.67% |
| 2022 Q1 | 3.04 Billion CNY | 1.35% |
| 2022 Q3 | 3.1 Billion CNY | 0.09% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 FY | 2.99 Billion CNY | 94.78% |
| 2021 Q4 | 2.99 Billion CNY | 0.0% |
| 2021 Q2 | 1.64 Billion CNY | 0.0% |
| 2020 Q4 | 1.53 Billion CNY | -0.12% |
| 2020 FY | 1.53 Billion CNY | 27.34% |
| 2020 Q2 | 1.27 Billion CNY | 0.0% |
| 2020 Q3 | 1.54 Billion CNY | 21.4% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q3 | 1.2 Billion CNY | 26.77% |
| 2019 Q1 | 953.92 Million CNY | 17.08% |
| 2019 Q2 | 953.92 Million CNY | 0.0% |
| 2019 FY | 1.2 Billion CNY | 48.43% |
| 2019 Q4 | 1.2 Billion CNY | 0.0% |
| 2018 Q4 | 814.74 Million CNY | 0.0% |
| 2018 Q2 | 714.86 Million CNY | 0.0% |
| 2018 Q1 | 714.86 Million CNY | 12.82% |
| 2018 Q3 | 814.73 Million CNY | 13.97% |
| 2018 FY | 814.74 Million CNY | 28.58% |
| 2017 Q1 | 580.21 Million CNY | 7.42% |
| 2017 Q4 | 633.66 Million CNY | 0.0% |
| 2017 FY | 633.66 Million CNY | 17.32% |
| 2017 Q3 | 633.66 Million CNY | 9.21% |
| 2017 Q2 | 580.21 Million CNY | 0.0% |
| 2016 FY | 540.12 Million CNY | 12.99% |
| 2016 Q2 | 519.87 Million CNY | 0.0% |
| 2016 Q1 | 519.87 Million CNY | 8.75% |
| 2016 Q3 | 540.12 Million CNY | 3.9% |
| 2016 Q4 | 540.12 Million CNY | 0.0% |
| 2015 Q4 | 478.04 Million CNY | 0.0% |
| 2015 Q2 | 471.25 Million CNY | 0.0% |
| 2015 Q3 | 478.04 Million CNY | 1.44% |
| 2015 FY | 478.04 Million CNY | 99.3% |
| 2015 Q1 | 471.25 Million CNY | 96.47% |
| 2014 FY | 239.85 Million CNY | 19.55% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q4 | 239.85 Million CNY | 0.0% |
| 2013 FY | 200.63 Million CNY | 7.0% |
| 2013 Q4 | 200.63 Million CNY | 0.0% |
| 2012 FY | 187.5 Million CNY | 0.0% |